Some consumers and businesses might see a little extra cash this summer as a result of the 2010 health care law. The Kaiser Family Foundation recently reported an estimated $1.3 billion in rebates will be delivered from health insurers who spent more than the law allotted on administrative expenses and profits.

Two recent books, Marcia Angell's The Truth About Drug Companies and Jerome Kassirer's On the Take are often grouped with other anti-pharmaceutical-industry tracts.

Adoption of a stakeholder approach is likely to undermine essentialresearch and developmentwhile doing little to curtail the HIV/AIDS epidemic.

Biopharma – especially big pharma – gets all sorts of grief for being large, stodgy, and unable to innovate (or evolve); this Corey Goodman interview represents the perspective well.

Before writing off these companies entirely, however (an ignorant reaction in any case),...

Little is known about the effects of DTC advertising, especially its impact on consumer behavior (as opposed to attitudes and knowledge) and, ultimately, on consumer health.

When R. J. Reynolds brought its Joe Camel cartoon character from France in 1988 for use in the United States, it launched a controversy that outlived the character itself.

Of the many factors that make improving the health system difficult, few challenges are greater than the misty-eyed recollection – often from genuinely distinguished practitioners – of how great things used to be.  Doctors were highly regarded authority figures, pure and beloved, while patients were meek and grateful in the presence of such brilliance and expertise.

It is important tomake an independent assessment of the likely effects of proposed advertising bans and other interventions in informational competition.